{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:41:51Z","timestamp":1794746511598,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Lesions of bone featuring osteoclast-like giant cells comprise a diverse group of entities, including giant cell tumor (GCT) of bone, chondroblastoma, and aneurysmal bone cyst, among others. The receptor activator of nuclear factor-\u03baB ligand (RANKL) has been implicated in the pathogenesis of GCT of bone and may play a role in the pathogenesis of other giant cell\u2013rich lesions as well. In addition, RANKL inhibitors (denosumab) have also been shown to have some efficacy in treating some giant cell\u2013rich lesions. Herein, we examine RANKL expression by RNA in situ hybridization in a total of 84 osseous lesions with a focus on chondroblastoma, GCT, fibrous dysplasia, and aneurysmal bone cyst. The lesions were tested for RANKL expression using a chromogenic RNA in situ hybridization assay. RANKL expression was identified in 24\/25 (96%) GCT, 24\/26 (92%) chondroblastomas, 6\/7 (86%) aneurysmal bone cysts, and 3\/16 (19%) patients with fibrous dysplasia. RANKL expression was statistically lower in chondroblastoma and aneurysmal bone cyst compared with GCT. RANKL reactivity in fibrous dysplasia was exclusively seen in the 3 cases with osteoclast-type giant cells. Our results indicate a high proportion of chondroblastomas, GCTs, and aneurysmal bone cysts express RANKL while reactivity in fibrous dysplasia is dependent on the presence of osteoclast-type giant cells. On the basis of the success of denosumab therapy for GCTs, our results indicate that it may be a potential therapeutic option in other primary osseous tumors.<\/jats:p>","DOI":"10.1097\/pas.0000000000001568","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T16:08:17Z","timestamp":1598026097000},"page":"1581-1590","source":"Crossref","is-referenced-by-count":14,"title":["Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy"],"prefix":"10.1097","volume":"44","author":[{"given":"David I.","family":"Suster","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Kurzawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Pozna\u0144 University of Medical Sciences"},{"name":"Pathology Department, University Hospital of Lord\u2019s Transfiguration, Partner of Karol Marcinkowski University of Medical Sciences, Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azfar","family":"Neyaz","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Jarzembowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Children\u2019s Hospital of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Lozano-Calderon","sequence":"additional","affiliation":[{"name":"Orthopaedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Raskin","sequence":"additional","affiliation":[{"name":"Orthopaedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schwab","sequence":"additional","affiliation":[{"name":"Orthopaedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Chebib","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PAT.0b013e3283463536","article-title":"RANK signalling in bone lesions with osteoclast-like giant cells","volume":"43","author":"Won","year":"2011","journal-title":"Pathology"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/mp.56.2.116","article-title":"Receptor activator of NF-KappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment","volume":"56","author":"Huang","year":"2003","journal-title":"Mol Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/PAS.0000000000001257","article-title":"Giant cell lesions of the maxillofacial skeleton express rankl by RNA in situ hybridization regardless of histologic pattern","volume":"43","author":"Stagner","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00590-017-1996-7","article-title":"Chondroblastoma in adult age","volume":"27","author":"Angelini","year":"2017","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00330-014-3506-1","article-title":"Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes","volume":"25","author":"Xie","year":"2015","journal-title":"Eur Radiol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/BPO.0000000000001293","article-title":"Functional and oncological outcome after treatment of chondroblastoma with intralesional curettage","volume":"39","author":"Ebeid","year":"2019","journal-title":"J Pediatr Orthop"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4143\/crt.2009.41.4.241","article-title":"A case of spine origin chondroblastoma metastasis to lung","volume":"41","author":"Sohn","year":"2009","journal-title":"Cancer Res Treat"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2017.01.028","article-title":"Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): for how long?","volume":"76","author":"Palmerini","year":"2017","journal-title":"Eur J Cancer"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2017.02.008","article-title":"Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls","volume":"63","author":"Roitman","year":"2017","journal-title":"Hum Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.joms.2014.06.456","article-title":"Management of central giant cell granuloma with subcutaneous denosumab therapy","volume":"72","author":"Naidu","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00586-013-2715-7","article-title":"Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts","volume":"22","author":"Lange","year":"2013","journal-title":"Eur Spine J"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trsl.2014.03.005","article-title":"Targeting receptor activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response","volume":"164","author":"Pelle","year":"2014","journal-title":"Transl Res"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ccr3.838","article-title":"Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report","volume":"24","author":"Calvert","year":"2017","journal-title":"Clin Case Rep"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000000343","article-title":"Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms","volume":"39","author":"Shahid","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1078-0432.CCR-16-0237","article-title":"Branched chain RNA in situ hybridization for androgen receptor splice variant AR-V7 as a prognostic biomarker for metastatic castration-sensitive prostate cancer","volume":"23","author":"Saylor","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0000000000000506","article-title":"Denosumab-treated giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2147\/OTT.S135867","article-title":"The RANK\/RANKL\/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy","volume":"10","author":"Sisay","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","article-title":"Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues","volume":"11","author":"Lui","year":"2015","journal-title":"Mol Med Rep"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation","volume":"156","author":"Huang","year":"2000","journal-title":"Am J Pathol"},{"key":"R24-20230922","first-page":"297","article-title":"The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts","volume":"16","author":"Zheng","year":"2001","journal-title":"Histol Histopathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12891-019-2855-y","article-title":"Aneurysmal bone cyst: results of an off label treatment with denosumab","volume":"20","author":"D\u00fcrr","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.otsr.2019.04.028","article-title":"Denosumab for treating aneurysmal bone cysts in children","volume":"105","author":"Raux","year":"2019","journal-title":"Orthop Traumatol Surg Res"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"e26926","DOI":"10.1002\/pbc.26926","article-title":"Denosumab treatment in aneurysmal bone cyst: evaluation of nine cases","volume":"65","author":"Kurucu","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"E654","DOI":"10.1097\/BRS.0000000000001350","article-title":"Interest of denosumab for the treatment of giant-cells tumors and aneurysmal bone cysts of the spine. About nine cases","volume":"41","author":"Dubory","year":"2016","journal-title":"Spine (Phila Pa 1976)"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00198-013-2585-1","article-title":"Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases","volume":"25","author":"Ganda","year":"2014","journal-title":"Osteoporos Int"},{"key":"R30-20230922","first-page":"253","article-title":"Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia","volume":"13","author":"Eller-Vainicher","year":"2016","journal-title":"Clin Cases Miner Bone Metab"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostictool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"Luke","year":"2017","journal-title":"Histopathology"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","article-title":"Denosumab: an emerging therapy in pediatric bone disorders","volume":"15","author":"Boyce","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/jc.2013-3081","article-title":"Effects of denosumab treatment and discontinuation on human growth plates","volume":"99","author":"Wang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/jc.2017-02025","article-title":"Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumor of bone","volume":"103","author":"Uday","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00264-017-3536-9","article-title":"How safe and effective is denosumab for bone giant cell tumour?","volume":"41","author":"Errani","year":"2017","journal-title":"Int Orthop"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:00:28Z","timestamp":1695423628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001568","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,20]]}}}